Diacylglycerol Signaling

9 PKC and the Control of Apoptosis
Dempsey, E. C., Newton, A. C., Mochly-Rosen, D., Fields, A. P., Reyland, M. E., Insel, P. A.,
et al. (2000). Protein kinase C isozymes and the regulation of diverse cell responses. American
Journal of Physiology, 279, L429–L438.
Deng, X., Ito, T., Carr, B., Mumby, M., & May, W. S., Jr. (1998). Reversible phosphorylation of
bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein
phosphatase 2a. The Journal of Biological Chemistry, 273, 34157–34163.
Detjen, K., Brembeck, F., Welzel, M., Kaiser, A., Haller, H., Wiedenmann, B., et al. (2000).
Activation of protein kinase C alpha inhibits growth of pancreatic cancer cells via p21(cip)mediated
G(1) arrest. Journal of Cell Science, 113, 3025–3035.
DeVries, T. A., Neville, M. C., & Reyland, M. E. (2002). Nuclear import of PKC delta is required for
apoptosis: Identification of a novel nuclear import sequence. EMBO Journal, 21, 6050–6060.
DeVries-Seimon, T. A., Ohm, A. M., Humphries, M. J., & Reyland, M. E. (2007). Induction of
apoptosis is driven by nuclear retention of protein kinase C delta. The Journal of Biological
Chemistry, 282, 22307–22314.
Dhanasekaran, D., & Reddy, E. (2008). JNK signaling in apoptosis. Oncogene, 27, 6245–6251.
Diaz-Meco, M., Berra, E., Municio, M., Sanz, L., Lozano, J., Dominguez, I., et al. (1993).
A dominant negative protein kinase Cz subspecies blocks NF-kB activation. Molecular and
Cellular Biology, 13, 4770–4775.
Diaz-Meco, M. T., Lallena, M. J., Monjas, A., Frutos, S., & Moscat, J. (1999). Inactivation of the
inhibitory kB protein kinase/nuclear factor kB pathway by par-4 expression potentiates tumor
necrosis factor alpha-induced apoptosis. The Journal of Biological Chemistry, 274, 19606–19612.
Diaz-Meco, M. T., & Moscat, J. (2008). AKT regulation and lung cancer: A novel role and mechanism
of action for the tumor suppressor par-4. Cell Cycle, 7, 2817–2820.
Diaz-Meco, M., Municio, M., Frutos, S., Sanchez, P., Lazano, J., Sanz, L., et al. (1996). The
product of par-4, a gene induced during apoptosis, interacts selectively with the atypical
isoforms of protein kinase C. Cell, 86, 777–786.
Ding, L., Wang, H., Lang, W., & Xiao, L. (2002). Protein kinase C-epsilon promotes survival of
lung cancer cells by suppressing apoptosis through dysregulation of the mitochondrial caspase
pathway. The Journal of Biological Chemistry, 277, 35305–35313.
Dooley, N. P., Baltuch, G. H., Groome, N., Villemure, J. G., & Yong, V. W. (1998). Apoptosis is
induced in glioma cells by antisense oligonucleotides to protein kinase C alpha and is enhanced
by cycloheximide. Neuroreport, 9, 1727–1733.
Doornbos, R. P., Theelen, M., van der Hoeven, P. C., van Blitterswijk, W. J., Verkleij, A. J., & van
Bergen en Henegouwen, P. M. (1999). Protein kinase C zeta is a negative regulator of protein
kinase B activity. The Journal of Biological Chemistry, 274, 8589–8596.
Eguchi, K. (2001). Apoptosis in autoimmune diseases. Internal Medicine, 40, 275–284.
Ekshyyan, O., & Aw, T. Y. (2004). Apoptosis: A key in neurodegenerative disorders. Current
Neurovascular Research, 1, 355–371.
Ellis, H., & Horvitz, H. R. (1986). Genetic control of programmed cell death in the nematode
c. Elegans. Cell, 44, 817–829.
El-Rayes, B. F., Ali, S., Philip, P. A., & Sarkar, F. H. (2008). Protein kinase C: A target for therapy
in pancreatic cancer. Pancreas, 36, 346–352.
Emoto, Y., Kisaki, H., Manome, Y., Kharbanda, S., & Kufe, D. (1996). Activation of protein
kinase C delta in human myeloid leukemia cells treated with 1-b-d-arabinofuranosylcytosine.
Blood, 87, 1990–1996.
Engers, R., Mrzyk, S., Springer, E., Fabbro, D., Weissgerber, G., Gernharz, C. D., et al. (2000).
Protein kinase C in human renal cell carcinomas: Role in invasion and differential isoenzyme
expression. British Journal of Cancer, 82, 1063–1069.
Erster, S., Mihara, M., Kim, R. H., Petrenko, O., & Moll, U. M. (2004). In vivo mitochondrial p53
translocation triggers a rapid first wave of cell death in response to DNA damage that can
precede p53 target gene activation. Molecular and Cellular Biology, 24, 6728–6741.
Espinosa, I., Briones, J., Bordes, R., Brunet, S., Martino, R., Sureda, A., et al. (2006). Membrane
PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in
patients with diffuse large B-cell lymphoma. Annals of Hematology, 85, 597–603.
209